Rye Brook Capital Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Pharmaceutical ETF
PPH
|
+$6.97M |
| 2 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$4.25M |
| 3 |
Amazon
AMZN
|
+$3.97M |
| 4 |
SK Telecom
SKM
|
+$2.79M |
| 5 |
Listed Funds Trust Roundhill Magnificent Seven ETF
MAGS
|
+$1.83M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$2.36M |
| 2 |
VanEck Semiconductor ETF
SMH
|
+$2.26M |
| 3 |
Tesla
TSLA
|
+$1.18M |
| 4 |
P
Everpure Inc
P
|
+$648K |
| 5 |
Astera Labs
ALAB
|
+$579K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Real Estate | 5.53% |
| 2 | Energy | 5.14% |
| 3 | Communication Services | 3.58% |
| 4 | Industrials | 2.84% |
| 5 | Consumer Discretionary | 2.64% |
Similar funds
Rye Brook Capital's Q2 2026 Portfolio in Review
As of Q2 2026, Rye Brook Capital held 44 positions worth $143M, up 31% from $108M the previous quarter. Its ten largest holdings account for 69% of the portfolio.
Rye Brook Capital deployed $26.1M of net new capital in Q2 2026, opening 16 new positions and adding to 17 existing holdings. Its largest new stake was VanEck Pharmaceutical ETF: 67,330 shares worth $7.36M.
By sector, the portfolio is most concentrated in Real Estate at 5.5% of assets, down from 6.8% a quarter earlier, followed by Energy and Communication Services.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $2.36M trimmed.
- Rye Brook Capital's largest Q2 2026 buy was VanEck Pharmaceutical ETF: 67,330 shares worth $7.36M.
- Rye Brook Capital added most to KraneShares CSI China Internet ETF in Q2 2026, an estimated $1.28M increase.
- Rye Brook Capital's biggest Q2 2026 reduction was Invesco QQQ Trust, cutting an estimated $2.36M.
- Rye Brook Capital fully exited Tesla in Q2 2026, selling an estimated $1.18M.
- Rye Brook Capital's ten largest holdings make up 69% of its $143M portfolio in Q2 2026.
- Rye Brook Capital opened 16 new positions and closed 4 in Q2 2026.
- Rye Brook Capital's portfolio value rose 31% quarter-over-quarter to $143M.
Based on Rye Brook Capital's 13F filing for Q2 2026, filed 20 Jul 2026.